Skip to main navigation Skip to search Skip to main content

Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalEuropean respiratory journal
Volume58
DOIs
Publication statusPublished - 5 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Covid-19
  • ARDS (Acute Respiratory Distress Syndrome)
  • Pharmacology

Cite this